The ICICI Prudential Healthcare ETF, managed by ICICI Prudential Asset Management Company, aims to replicate the Nifty Healthcare Index's performance, providing sector-specific exposure to healthcare investments.

This open-ended fund employs a tracking strategy with a minimal tracking error of 0.02%, ensuring returns closely align with the NIFTY Healthcare TRI benchmark for efficient performance.

The portfolio is heavily concentrated in Pharmaceuticals & Biotechnology, comprising 76.0% of assets, with top holdings like Sun Pharmaceutical Industries Ltd. at 17.96% and MAX Healthcare Institute Ltd. at 8.96%.

Performance metrics indicate a 1-year decline of -4.1%, while the 3-year CAGR stands robust at 20.3%, highlighting volatility yet promising growth over a longer horizon.

With an expense ratio of just 0.15% and a fund size of ₹141.95 Cr as of Aug 2025, this ETF remains accessible, with liquidity supported by its listing on major exchanges.